TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Upper Extremity score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall satisfaction with consent process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal sensitivity in parent-child interaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total operative fluoroscopy time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of preeclampsia
Endpoint domain: Adverse events/effects
Primary endpoint: positive behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Naloxone dispensings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of home-based cryotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-adjusted life years (QALYs)
Endpoint domain: Life impact
Primary endpoint: Satisfaction rates from treatments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Defecation quality improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients reaching the target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reader performance to predict upstaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global health QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Knowledge test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: situational interest
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Local recurrence-free survival (LR)
Endpoint domain: Mortality/survival
Primary endpoint: Willingness to donate organs after death
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Registration with the Centralised Organ Donation Register (CODR)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Awareness of ways to register as a prospective organ donor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decrease in lung volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prediction of hip fracture risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sickness absence
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: improvement in muscle toning exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gastroenteropathy PRO scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: scores of pathological changes of gastric mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in major or clinically relevant nonmajor bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of loose stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of lower respiratory infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Growth rate (g/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum IgE levels towards birch, alder, hazel, hornbeam and beech
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T-cell reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IgG4 reactivity towards birch and alder, hazel, hornbeam and beech
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity in detecting pulmonary nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reading time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Distress due to altered appearance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Provision of care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Visual Analog Scale pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall OSATS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of pain areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stair Negotiation Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum height of obstacles crossed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEH score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dice similarity coefficient (DSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Hausdorff distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance correlation coefficient (CCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance in the 30-15 Intermittent Fitness Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Errors made during the soccer-specific reactive agility test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response time on the Stroop test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Declines in glucose-corrected sodium concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Air pollutant levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean visual acuity letter score over 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent change in lumbar spine BMD from baseline to month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in annualized height velocity (aHV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thrombotic cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean body temperature on the 3rd day of hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral capillary oxygen saturations (SpO2) on the 3rd day of hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical IPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe IPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTG level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-reported physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ACR20 response at week 260
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAQ Disability Index minimal clinically important difference (≥0.35)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dactylitis count of 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASS-stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Anxiety Interview
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive performance of neural networks for appropriate device therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Technical success of VCD interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Resumption of ambulation after 5 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fibroid volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Compliance rate to criteria
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: NMB reversal duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative bleeding until postoperative day 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in interleukin‐6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean difference in delta VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of reduction in VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical effectiveness of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pain at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROMs of the knee improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choroidal Vascularity Index (CVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost per diabetes case prevented
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: absolute risk reduction
Endpoint domain: Mortality/survival
Primary endpoint: glycemic variability percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total user-requested insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in the incidence of newborn deaths
Endpoint domain: Mortality/survival
Primary endpoint: Incidence rates of fetal macrosomia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rates of hyperbilirubinemia
Endpoint domain: Adverse events/effects
Primary endpoint: changes in body fluid balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall ocular surface disease index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vision-related function score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tear film objective scatter index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to participate in prevention interventions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol-related impaired work performance (presenteeism)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of index ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MoCA and MBI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: latency of P300
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: effective rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: worsening HF events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: adjusted hazard ratios for primary outcome
Endpoint domain: Mortality/survival
Primary endpoint: plant length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of seeds/plant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: seed weight/plant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of mild anaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of falciparum malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of patients with a modified Barrow Neurological Institute Pain Intensity Score (BNI) between I and III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Comfort situation scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cycles to 2 mm plantar movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary fixation strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Construct stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean compression rate (MCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct identification of prescription drug abuse issue
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Exhibition of stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in scaling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sit-to-stand test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDL-cholesterol change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DM (Diaphragmatic Mobility)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Peak Work Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak RER
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SWM results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BBT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA score (wrist and coordination component)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: acromegaly symptoms maintenance or improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preference to continue with oral treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fatigue limit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: App feasibility rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean score of app usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: euploidy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: spontaneous preterm birth before 35 weeks
Endpoint domain: Mortality/survival
Primary endpoint: spontaneous preterm birth before 37 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Clinical success at ECR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to establish L-EUC, S-EUC, and S-UC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: sebum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: reported diarrhoea rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Psychomotor speed (Symbol Digit Modality Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental health (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Middle Cerebral Artery Flow Velocity (MFV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decrease in iPTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: improvement in vascular function (PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: decrease in log flOPN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of acute exacerbation of COPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: duration of acute exacerbation of COPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: dyspnea scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: fracture load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug removal rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anti-RBD seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: geometric mean neutralizing titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Healing score on Day 10 postextraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical bone changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functional Lysholm score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occult nodal metastasis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: neck muscles PPT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: left lateral flexion ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Non-Invasive Hepatic Metastasis (NIHM)
Endpoint domain: Adverse events/effects
Primary endpoint: Unablated Tumor Progression
Endpoint domain: Adverse events/effects
Primary endpoint: number of explosions (risk-taking outcome)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cortisol change post-exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Participant retention at 16-week follow-up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: new onset heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in drug craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in Rey Auditory Verbal Learning test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: increase in short latency afferent inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Predicted 30-year atherosclerotic cardiovascular disease risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: frequency of sex
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Mean change from baseline in knowledge and skill performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first self-reported recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cement mantle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: air bubble formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: survivorship of the femoral component
Endpoint domain: Mortality/survival
Primary endpoint: tissue inhibitor of matrix metalloproteinase 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: soluble ST2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-terminal propeptide of collagen III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fine motor development delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate-to-vigorous intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of pain intensity (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of UT muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diameter of MTrP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional blood flow volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Affective depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMRS‐P points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pro‐social activities' subscale of SFS‐P
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: SOD, GSH‐Px, CAT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normal function at 2 hours post dose
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Satisfaction with treatment at 2 hours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Migraine improvement at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction from anxiety management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coronary artery calcium (CAC) severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of ascending thoracic aortic calcification (AsAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes